Disclosures: Jasmin Elurbide: Nothing to Disclose, Leticia Colyn: Nothing to Disclose, Maria Ujue Latasa: Nothing to Disclose, Iker Uriarte: Nothing to Disclose, Stefano Mariani: Nothing to Disclose, Amaya Lopez-Pascual: Nothing to Disclose, Emiliana Valbuena: Nothing to Disclose, Borja Castello-Uribe: Nothing to Disclose, Robert Arnes Benito: Nothing to Disclose, Elena Adan-Villaescusa: Nothing to Disclose, Mikel Azkargorta: Nothing to Disclose, Felix Elortza: Nothing to Disclose, Hanghang Wu: Nothing to Disclose, Marcin Krawczyk: Nothing to Disclose, Kai Markus Schneider: Nothing to Disclose, Bruno Sangro: Nothing to Disclose, Luca Aldrighetti: Nothing to Disclose, Francesca Ratti: Nothing to Disclose, Andrea Casadei-Gardini: Nothing to Disclose, Jose Marin: Nothing to Disclose, Irene Amat: Nothing to Disclose, Jesus Urman: Nothing to Disclose, Maria Arechederra: Nothing to Disclose, Maria Martinez-Chantar: Nothing to Disclose, Christian Trautwein: Nothing to Disclose, Meritxell Huch: Nothing to Disclose, Francisco Javier Cubero: Nothing to Disclose, Carmen Berasain: Nothing to Disclose, Maite Fernandez-Barrena: Nothing to Disclose, Matas vila: Nothing to Disclose 1842 PIVKA-II AS A PROGNOSTIC FACTOR FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA AND WITH NORMAL SERUM ALPHA-FETOPROTEIN LEVELS Chun-Ting Ho 1 Elise Chia-Hui Tan 2 Tzu-Han Ma 3 Yi-Hsiang Huang 1 Ming-Chih Hou 1 Jaw-Ching Wu 3 Chien-Wei Su 1 , 1 Taipei Veterans General Hospital, 2 China Medical University, 3 National Yang Ming Chiao Tung University Background: Hepatocellular carcinoma (HCC) patients with normal serum alpha-fetoprotein (AFP) levels ( 100 mAU/mL
Murphy, M.P
Chang et al., 2023)
Sometimes they are communicating too much or too little with each other
